Cost-Effectiveness Analysis of Bendamustine-Rituximab Treatment Compared with Fludarabine-Rituximab Treatment, in Patients with Indolent Non-Hodgkin’s Lymphoma in Costa Rica

May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.497
https://www.valueinhealthjournal.com/article/S1098-3015(14)00548-8/fulltext
Section Title : Cancer
Section Order : 1547
First Page : A85
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00548-8&doi=10.1016/j.jval.2014.03.497
HEOR Topics :
Tags :
Regions :